United States Antibody Drug Conjugate Market Report 2016

October 2016 | 114 pages | ID: U96EE51D2B2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antibody Drug Conjugate

Revenue, means the sales value of Antibody Drug Conjugate

This report studies sales (consumption) of Antibody Drug Conjugate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Seattle Genetics/Takeda
• Roche
• ImmunoGen
• Immunomedics
• Pfizer
• Celldex Therapeutics
• Millennium Pharmaceuticals
• Bayer HealthCare
• Mersana Therapeutics
• Heidelberg Pharma
• Oxford BioTherapeutics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Adcetris
• Kadcyla
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Antibody Drug Conjugate in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Antibody Drug Conjugate Market Report 2016

1 ANTIBODY DRUG CONJUGATE OVERVIEW

1.1 Product Overview and Scope of Antibody Drug Conjugate
1.2 Classification of Antibody Drug Conjugate
  1.2.1 Adcetris
  1.2.2 Kadcyla
  1.2.3 Type III
1.3 Application of Antibody Drug Conjugate
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Antibody Drug Conjugate (2011-2021)
  1.4.1 United States Antibody Drug Conjugate Sales and Growth Rate (2011-2021)
  1.4.2 United States Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTIBODY DRUG CONJUGATE COMPETITION BY MANUFACTURERS

2.1 United States Antibody Drug Conjugate Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antibody Drug Conjugate Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antibody Drug Conjugate Average Price by Manufactures (2015 and 2016)
2.4 Antibody Drug Conjugate Market Competitive Situation and Trends
  2.4.1 Antibody Drug Conjugate Market Concentration Rate
  2.4.2 Antibody Drug Conjugate Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTIBODY DRUG CONJUGATE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Antibody Drug Conjugate Sales and Market Share by Type (2011-2016)
3.2 United States Antibody Drug Conjugate Revenue and Market Share by Type (2011-2016)
3.3 United States Antibody Drug Conjugate Price by Type (2011-2016)
3.4 United States Antibody Drug Conjugate Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ANTIBODY DRUG CONJUGATE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Antibody Drug Conjugate Sales and Market Share by Application (2011-2016)
4.2 United States Antibody Drug Conjugate Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ANTIBODY DRUG CONJUGATE MANUFACTURERS PROFILES/ANALYSIS

5.1 Seattle Genetics/Takeda
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Roche
  5.2.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 ImmunoGen
  5.3.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Immunomedics
  5.4.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer
  5.5.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Celldex Therapeutics
  5.6.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Millennium Pharmaceuticals
  5.7.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bayer HealthCare
  5.8.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Mersana Therapeutics
  5.9.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Heidelberg Pharma
  5.10.2 Antibody Drug Conjugate Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Oxford BioTherapeutics

6 ANTIBODY DRUG CONJUGATE MANUFACTURING COST ANALYSIS

6.1 Antibody Drug Conjugate Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Antibody Drug Conjugate

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Antibody Drug Conjugate Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ANTIBODY DRUG CONJUGATE MARKET FORECAST (2016-2021)

10.1 United States Antibody Drug Conjugate Sales, Revenue Forecast (2016-2021)
10.2 United States Antibody Drug Conjugate Sales Forecast by Type (2016-2021)
10.3 United States Antibody Drug Conjugate Sales Forecast by Application (2016-2021)
10.4 Antibody Drug Conjugate Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antibody Drug Conjugate
Table Classification of Antibody Drug Conjugate
Figure United States Sales Market Share of Antibody Drug Conjugate by Type in 2015
Figure Adcetris Picture
Figure Kadcyla Picture
Table Application of Antibody Drug Conjugate
Figure United States Sales Market Share of Antibody Drug Conjugate by Application in 2015
Figure United States Antibody Drug Conjugate Sales and Growth Rate (2011-2021)
Figure United States Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Table United States Antibody Drug Conjugate Sales of Key Manufacturers (2015 and 2016)
Table United States Antibody Drug Conjugate Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antibody Drug Conjugate Sales Share by Manufacturers
Figure 2016 Antibody Drug Conjugate Sales Share by Manufacturers
Table United States Antibody Drug Conjugate Revenue by Manufacturers (2015 and 2016)
Table United States Antibody Drug Conjugate Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antibody Drug Conjugate Revenue Share by Manufacturers
Table 2016 United States Antibody Drug Conjugate Revenue Share by Manufacturers
Table United States Market Antibody Drug Conjugate Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antibody Drug Conjugate Average Price of Key Manufacturers in 2015
Figure Antibody Drug Conjugate Market Share of Top 3 Manufacturers
Figure Antibody Drug Conjugate Market Share of Top 5 Manufacturers
Table United States Antibody Drug Conjugate Sales by Type (2011-2016)
Table United States Antibody Drug Conjugate Sales Share by Type (2011-2016)
Figure United States Antibody Drug Conjugate Sales Market Share by Type in 2015
Table United States Antibody Drug Conjugate Revenue and Market Share by Type (2011-2016)
Table United States Antibody Drug Conjugate Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antibody Drug Conjugate by Type (2011-2016)
Table United States Antibody Drug Conjugate Price by Type (2011-2016)
Figure United States Antibody Drug Conjugate Sales Growth Rate by Type (2011-2016)
Table United States Antibody Drug Conjugate Sales by Application (2011-2016)
Table United States Antibody Drug Conjugate Sales Market Share by Application (2011-2016)
Figure United States Antibody Drug Conjugate Sales Market Share by Application in 2015
Table United States Antibody Drug Conjugate Sales Growth Rate by Application (2011-2016)
Figure United States Antibody Drug Conjugate Sales Growth Rate by Application (2011-2016)
Table Seattle Genetics/Takeda Basic Information List
Table Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Antibody Drug Conjugate Sales Market Share (2011-2016)
Table ImmunoGen Basic Information List
Table ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table ImmunoGen Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Immunomedics Basic Information List
Table Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Millennium Pharmaceuticals Basic Information List
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Mersana Therapeutics Basic Information List
Table Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mersana Therapeutics Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Heidelberg Pharma Basic Information List
Table Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heidelberg Pharma Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Oxford BioTherapeutics Basic Information List
Table Oxford BioTherapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oxford BioTherapeutics Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Manufacturing Process Analysis of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2015
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure United States Antibody Drug Conjugate Production and Growth Rate Forecast (2016-2021)
Figure United States Antibody Drug Conjugate Revenue and Growth Rate Forecast (2016-2021)
Table United States Antibody Drug Conjugate Production Forecast by Type (2016-2021)
Table United States Antibody Drug Conjugate Consumption Forecast by Application (2016-2021)